High-Dose Atorvastatin Enhances the Decline in Inflammatory Markers in Patients With Acute Coronary Syndromes in the MIRACL Study - Concepedia

Concepedia

Publication | Closed Access

High-Dose Atorvastatin Enhances the Decline in Inflammatory Markers in Patients With Acute Coronary Syndromes in the MIRACL Study

401

Citations

24

References

2003

Year

Scott Kinlay, Gregory G. Schwartz, Anders Olsson, Nader Rifai, S. J. Leslie, William J. Sasiela, Michael Szarek, Peter Libby, Peter Ganz

Abstract

High-dose atorvastatin potentiated the decline in inflammation in patients with acute coronary syndromes. This supports the value of early statin therapy in these patients.

References

	Year	Citations

Page 1